UnitedHealth Faces Key Questions on Earnings and Medical Costs

UnitedHealth Group Incorporated (UNH) is set to release its third-quarter earnings on October 13, with investors focusing on whether the company can sustain its second-quarter rebound. Key concerns revolve around medical costs and Medicare Advantage (MA) profitability.

UnitedHealthcare’s medical cost ratio (MCR) improved to 86.7% in Q2 from 89.4% a year earlier, with operating earnings rising to $3.9 billion from $2.1 billion. However, this improvement included $860 million in favorable medical reserve development. Investors will be watching underlying medical costs, Medicare utilization, commercial cost trends, specialty-drug inflation, and provider coding intensity. Management’s full-year MCR outlook of 88.1% will also be closely monitored.

The second major question is whether UnitedHealthcare can improve MA profitability without significant member losses. MA membership dropped by 785,000 from a year earlier, with management expecting a full-year decline of roughly 1.1 million members. The company has been adjusting benefits, pricing, networks, and market exposure to improve returns, aiming for Medicare margins above 3% for 2026. Investors will watch enrollment, retention, benefit changes for 2027, and any updates to the attrition forecast.

Peers like Humana Inc. (HUM) and Elevance Health, Inc. (ELV) are also grappling with rising medical cost trends. Humana’s insurance benefit ratio rose to 91.2% from 89.9%, while Elevance’s benefit expense ratio increased to 89.7% from 88.9%. UnitedHealth’s shares have gained 15.1% year-to-date, trading at a forward price-to-earnings ratio of 17.28, above the industry average of 15.20. The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is $19.85 per share, implying a 21.4% improvement from the previous year.